Soldner A[au] - Search Results

Year	Number of Results
1996	1
1997	1
1998	3
1999	3
2000	2
2016	1
2017	1
2022	0

1

Preparation of Supported Palladium Catalysts using Deep Eutectic Solvents.

Iwanow M, Finkelmeyer J, Söldner A, Kaiser M, Gärtner T, Sieber V, König B. Iwanow M, et al. Among authors: soldner a. Chemistry. 2017 Sep 12;23(51):12467-12470. doi: 10.1002/chem.201702790. Epub 2017 Sep 4. Chemistry. 2017. PMID: 28787096

2

Use of a disulfide cross-linking strategy to study muscarinic receptor structure and mechanisms of activation.

Zeng FY, Hopp A, Soldner A, Wess J. Zeng FY, et al. Among authors: soldner a. J Biol Chem. 1999 Jun 4;274(23):16629-40. doi: 10.1074/jbc.274.23.16629. J Biol Chem. 1999. PMID: 10347230 Free article.

3

Grapefruit juice activates P-glycoprotein-mediated drug transport.

Soldner A, Christians U, Susanto M, Wacher VJ, Silverman JA, Benet LZ. Soldner A, et al. Pharm Res. 1999 Apr;16(4):478-85. doi: 10.1023/a:1011902625609. Pharm Res. 1999. PMID: 10227700

4

The renin-angiotensin-aldosterone system: focus on its distinct role in arterial hypertension and its various inhibitors as a therapeutic strategy to effectively lower blood pressure.

Soldner A, Spahn-Langguth H, Mutschler E. Soldner A, et al. Pharmazie. 1996 Nov;51(11):783-99. Pharmazie. 1996. PMID: 8985974 Review.

5

Preparation of Magnesium, Cobalt and Nickel Ferrite Nanoparticles from Metal Oxides using Deep Eutectic Solvents.

Söldner A, Zach J, Iwanow M, Gärtner T, Schlosser M, Pfitzner A, König B. Söldner A, et al. Chemistry. 2016 Sep 5;22(37):13108-13. doi: 10.1002/chem.201602821. Epub 2016 Aug 12. Chemistry. 2016. PMID: 27514793

6

Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and caco-2 cell monolayers.

Soldner A, Benet LZ, Mutschler E, Christians U. Soldner A, et al. Br J Pharmacol. 2000 Mar;129(6):1235-43. doi: 10.1038/sj.bjp.0703150. Br J Pharmacol. 2000. PMID: 10725273 Free PMC article.

7

A radioreceptor assay for the analysis of AT1-receptor antagonists. Correlation with complementary LC data reveals a potential contribution of active metabolites.

Soldner A, Spahn-Langguth H, Palm D, Mutschler E. Soldner A, et al. J Pharm Biomed Anal. 1998 May;17(1):111-24. doi: 10.1016/s0731-7085(97)00240-9. J Pharm Biomed Anal. 1998. PMID: 9608433 Clinical Trial.

8

Lactonization is the critical first step in the disposition of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin.

Jacobsen W, Kuhn B, Soldner A, Kirchner G, Sewing KF, Kollman PA, Benet LZ, Christians U. Jacobsen W, et al. Among authors: soldner a. Drug Metab Dispos. 2000 Nov;28(11):1369-78. Drug Metab Dispos. 2000. PMID: 11038166

9

Pharmacokinetics of methylprednisolone and prednisolone after single and multiple oral administration.

Rohatagi S, Barth J, Möllmann H, Hochhaus G, Soldner A, Möllmann C, Derendorf H. Rohatagi S, et al. Among authors: soldner a. J Clin Pharmacol. 1997 Oct;37(10):916-25. doi: 10.1002/j.1552-4604.1997.tb04266.x. J Clin Pharmacol. 1997. PMID: 9505983 Clinical Trial.

10

HPLC assays to simultaneously determine the angiotensin-AT1 antagonist losartan as well as its main and active metabolite EXP 3174 in biological material of humans and rats.

Soldner A, Spahn-Langguth H, Mutschler E. Soldner A, et al. J Pharm Biomed Anal. 1998 Jan;16(5):863-73. doi: 10.1016/s0731-7085(97)00128-3. J Pharm Biomed Anal. 1998. PMID: 9535198

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results